We reviewed consecutive patients (n = 12) at McLean Hospital from 1990 through 1991 treated with the combination of the atypical antipsychotic agent clozapine and electroconvulsive therapy (ECT). There were no adverse effects. Three patients had a marked clinical improvement, one a moderate response, four a minimal response, two minimal to no response, and two no response. Using daily doses of up to 550 mg clozapine, this combination appears to be safe, and may be useful in some patients with treatment-refractory psychosis.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
clozapine electroconvulsive
8
electroconvulsive therapy
8
response minimal
8
minimal response
8
combined clozapine
4
therapy reviewed
4
reviewed consecutive
4
consecutive patients
4
patients mclean
4
mclean hospital
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!